Licensing & IP Strategy

    From IP to impact — structure deals that respect the work. We support licensing pathway clarity and strategic introductions in med-tech, healthcare AI, and advanced materials (including graphene).

    What this is

    • A clarity-first approach to licensing: pathway, counterparties, and realistic terms
    • A bridge between technical claims and commercial reality
    • Strategic introductions when there is clear fit

    What this isn't

    • Not a broker-dealer, law firm, or fund manager
    • Not a public "deal marketplace"
    • Not a promise of funding, acquisition, or outcomes

    What we offer

    Licensing pathway clarity

    Exclusive vs. non-exclusive options, staged transfers, co-development structures, and practical commercialization pathways based on evidence and constraints.

    Submit request →

    Strategic introductions (fit-driven)

    Introductions to aligned operators or buyers in med-tech, healthcare AI, and advanced materials — based on fit and readiness, not noise.

    Submit request →

    Term review coordination

    We coordinate review support for LOIs/term sheets with qualified professionals and help translate terms into practical outcomes and risks.

    Submit request →

    What we look for

    • Graphene & advanced materials with credible manufacturing path and real use case
    • Med-tech devices with clear clinical workflow fit
    • AI in healthcare with defensible data assumptions and usable deployment path
    • Diagnostics, wearables, and platforms where adoption constraints are understood

    Process

    Submit intake

    Share your IP summary, status, and goals.

    Fit review

    We assess evidence strength, pathway realism, and transaction feasibility.

    Pathway + counterparties

    If there's fit, we define a pathway and identify aligned counterparties.

    Execution support

    Where execution requires registered or licensed professionals, we coordinate with appropriately qualified parties.

    Disclaimers & legal clarity

    GigHz is not a broker-dealer, law firm, or fund manager. We provide research, strategic guidance, and facilitation. Where transaction execution requires registered or licensed professionals, we coordinate with appropriately qualified parties. Nothing on this page is legal, financial, or medical advice.

    Start a licensing conversation

    If you have IP and want clarity on pathway and fit, submit a short request and we'll respond by email.

    Submit request

    Written and reviewed by Pouyan Golshani, MD, Interventional Radiologist — Last updated July 15, 2025